Gerald Wallace

1.1k total citations
18 papers, 890 citations indexed

About

Gerald Wallace is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Cell Biology. According to data from OpenAlex, Gerald Wallace has authored 18 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 5 papers in Molecular Biology and 4 papers in Cell Biology. Recurrent topics in Gerald Wallace's work include Calpain Protease Function and Regulation (3 papers), Glioma Diagnosis and Treatment (3 papers) and Genetics and Neurodevelopmental Disorders (3 papers). Gerald Wallace is often cited by papers focused on Calpain Protease Function and Regulation (3 papers), Glioma Diagnosis and Treatment (3 papers) and Genetics and Neurodevelopmental Disorders (3 papers). Gerald Wallace collaborates with scholars based in United States and Japan. Gerald Wallace's co-authors include Naren L. Banik, Arabinda Das, Swapan K. Ray, Abhay Varma, J. A. Smith, Pierre Giglio, Sunil J. Patel, Alexey Vertegel, John Barry and William A. Vandergrift and has published in prestigious journals such as Neurology, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Gerald Wallace

17 papers receiving 877 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerald Wallace United States 12 404 277 157 102 101 18 890
Jorge Marcondes de Souza Brazil 21 481 1.2× 322 1.2× 128 0.8× 157 1.5× 68 0.7× 70 1.8k
Timothy P. Kegelman United States 14 490 1.2× 291 1.1× 185 1.2× 71 0.7× 173 1.7× 28 983
Winston Walters United States 14 563 1.4× 513 1.9× 194 1.2× 258 2.5× 78 0.8× 22 1.3k
Elena Sokolova Russia 25 983 2.4× 277 1.0× 50 0.3× 66 0.6× 99 1.0× 40 1.6k
Era Taoufik Greece 15 399 1.0× 242 0.9× 91 0.6× 34 0.3× 57 0.6× 24 953
Jinpyo Hong South Korea 18 481 1.2× 256 0.9× 48 0.3× 62 0.6× 70 0.7× 34 1.1k
Raul Krauss United States 11 520 1.3× 349 1.3× 44 0.3× 67 0.7× 136 1.3× 14 1.0k
Grace Woodruff United States 13 529 1.3× 391 1.4× 133 0.8× 82 0.8× 69 0.7× 15 965
Margot Mayer Germany 7 443 1.1× 281 1.0× 116 0.7× 119 1.2× 43 0.4× 12 1.0k
MinHee K. Ko United States 16 440 1.1× 95 0.3× 40 0.3× 49 0.5× 85 0.8× 39 1.2k

Countries citing papers authored by Gerald Wallace

Since Specialization
Citations

This map shows the geographic impact of Gerald Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Wallace more than expected).

Fields of papers citing papers by Gerald Wallace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Wallace. The network helps show where Gerald Wallace may publish in the future.

Co-authorship network of co-authors of Gerald Wallace

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald Wallace. A scholar is included among the top collaborators of Gerald Wallace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald Wallace. Gerald Wallace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wallace, Gerald, et al.. (2024). PML on Belimumab Therapy and Treatment with Pembrolizumab. Neurology. 103(7_Supplement_1).
2.
Haque, Azizul, Arabinda Das, Supriti Samantaray, et al.. (2022). Premarin Reduces Neurodegeneration and Promotes Improvement of Function in an Animal Model of Spinal Cord Injury. International Journal of Molecular Sciences. 23(4). 2384–2384. 6 indexed citations
3.
Wallace, Gerald, et al.. (2021). Precision Therapy for Brain Tumors in Hereditary Syndromes. Current Treatment Options in Oncology. 22(9). 80–80. 1 indexed citations
4.
Wehrle, Chase J., Asad Ullah, Margaret A. Sinkler, et al.. (2020). Paraneoplastic Limbic Encephalitis in a Patient with Primary Well-differentiated Teratoma and Metastatic Poorly Differentiated Embryonal Carcinoma.. The Yale Journal of Biology and Medicine. 93(4). 495–500. 1 indexed citations
5.
Das, Arabinda, Fraser Henderson, Stephen Lowe, et al.. (2018). Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastoma. Cancer Chemotherapy and Pharmacology. 82(6). 945–952. 16 indexed citations
6.
Wallace, Gerald, et al.. (2014). Effects of a novel orally administered calpain inhibitor SNJ‐1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis. Journal of Neurochemistry. 130(2). 268–279. 37 indexed citations
7.
Wallace, Gerald, Swapan K. Ray, Sunil J. Patel, et al.. (2013). Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma. Metabolic Brain Disease. 28(3). 355–366. 15 indexed citations
8.
Wallace, Gerald, Pierre Giglio, Abhay Varma, et al.. (2013). Multi-targeted DATS prevents tumor progression and promotes apoptosis in ectopic glioblastoma xenografts in SCID mice via HDAC inhibition. Journal of Neuro-Oncology. 114(1). 43–50. 60 indexed citations
9.
Varma, Abhay, Arabinda Das, Gerald Wallace, et al.. (2013). Spinal Cord Injury: A Review of Current Therapy, Future Treatments, and Basic Science Frontiers. Neurochemical Research. 38(5). 895–905. 179 indexed citations
10.
Das, Arabinda, Gerald Wallace, Sunil J. Patel, et al.. (2013). Abstract 2183: PF-02341066 (crizotinib), a dual ALK/c-Met inhibitor, for inhibiting growth of glioblastoma.. Cancer Research. 73(8_Supplement). 2183–2183. 1 indexed citations
11.
Das, Arabinda, et al.. (2012). Understanding the basic mechanisms underlying seizures in mesial temporal lobe epilepsy and possible therapeutic targets: A review. Journal of Neuroscience Research. 90(5). 913–924. 57 indexed citations
12.
Wallace, Gerald, Arabinda Das, William A. Vandergrift, et al.. (2012). Drug Resistance in Glioblastoma: A Mini Review. Neurochemical Research. 37(6). 1192–1200. 204 indexed citations
13.
Das, Arabinda, Gerald Wallace, Rüssel J. Reiter, et al.. (2012). Overexpression of melatonin membrane receptors increases calcium‐binding proteins and protects VSC4.1 motoneurons from glutamate toxicity through multiple mechanisms. Journal of Pineal Research. 54(1). 58–68. 22 indexed citations
14.
Das, Arabinda, Gerald Wallace, Misty L. McDowell, et al.. (2012). Hippocampal tissue of patients with refractory temporal lobe epilepsy is associated with astrocyte activation, inflammation, and altered expression of channels and receptors. Neuroscience. 220. 237–246. 174 indexed citations
15.
Das, Arabinda, M. Kelly Guyton, Gerald Wallace, et al.. (2012). Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats. Journal of Neurochemistry. 124(1). 133–146. 50 indexed citations
16.
Guyton, M. Kelly, Arabinda Das, Supriti Samantaray, et al.. (2010). Calpeptin attenuated inflammation, cell death, and axonal damage in animal model of multiple sclerosis. Journal of Neuroscience Research. 88(11). 2398–2408. 43 indexed citations
17.
Ogle, Molly E., et al.. (2008). Erythropoietin attenuates intracerebral hemorrhage by diminishing matrix metalloproteinases and maintaining blood-brain barrier integrity in mice. Acta neurochirurgica. Supplementum. 105. 105–112. 23 indexed citations
18.
Wallace, Gerald. (1989). Letters. Academic Therapy. 25(1). 112–112. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026